Panel Discussion: Shaping the Future of Ancillary Materials in Cell & Gene Therapy Insights from ISO Standard Development
Time: 9:10 am
day: Conference Day Two
Details:
- Firsthand experience contributing to a new ISO standard, focused on ancillary materials used in advanced therapies
- Overview of the U.S. TAG validation process and transition to a New Work Item Proposal within the ISO framework
- What this upcoming standard means for developers, manufacturers, and regulators over the next 3 to 4 years
